The Role of Non-Animal Recombinant Collagen Proteins in Biomedical Applications: From Vaccine Stabilization to Artificial Organs

For decades, GELITA has been providing specialised collagen for vaccine stabilisation and applications in bioscience. This presentation delves into the production and use of recombinant collagen proteins and peptides, focusing on their role in vaccine stabilisation and various biomedical applications. As we transition to biotechnological advancements, we explore how genetically engineered collagen peptides replicate the stabilising properties of their animal-derived counterparts, while also offering additional benefits such as scalability and reduced ethical concerns. A similar transition will be highlighted for the use of genetically engineered collagen protein in bioinks and scaffolding, leading into advanced 3D bioprinting of organoids and artificial organs. The discussion will underscore the gradual industry shift towards non-animal sourced excipients, driven by advancements in biotechnology and evolving regulatory and consumer preferences.